ID consultant/Deputy Director Wesfarmers Centre of Vaccines and Infectious Diseases
Telethon Kids Institute
Perth, Western Australia, Australia
Charlie McLeod is an Infectious Diseases early career clinician researcher and a Deputy director at the Wesfarmers Centre for Vaccines and Infectious Diseases based at the Perth Children’s Hospital and Telethon Kids Institute in Western Australia. They belong to the Adaptive Health Intelligence Unit; a group comprising ~35 individuals with diverse expertise who are committed to the design and implementation of patient-centred, policy driven research using innovative clinical trial methodologies and analytic approaches. McLeod has an outstanding track record relative to career stage (1.5FTE post PhD) and recognised expertise in clinical trial methodology, consumer engagement and patient-reported outcome measure development, vaccine trials, paediatrics, infectious diseases and public health policy. McLeod has received $10.4M in grant funding to date (CIA $3.9M) and is currently co-leading the Platform Trial in COVID-19 priming and BOOsting (PICOBOO), an $8M MRFF funded multi-site adaptive platform trial evaluating different COVID-19 booster strategies in immunocompetent Australians. They have also driven the establishment of ADAPTIVAX – a national vaccine trial network comprising >20 investigators from WA, SA, NSW, Victoria, NT and Tasmania that will strengthen collaborations across institutions and geographical regions, improve research efficiency, reduce research waste and optimise the translation of evidence generated from vaccine trials into practice and policy in Australia.
Disclosure(s): No financial relationships to disclose
Thursday, October 17, 2024
11:30 AM – 11:45 AM US PT